CCS Associates, Inc. (CCSA) is pleased to announce their collaboration with Children Oncology Group (COG) in support of clinical and translational research in infants, children, and adolescent patient populations. COG, a National Cancer Institute (NCI) supported clinical trials group, is the world’s largest organization devoted exclusively to pediatric cancer research. To kick-off this collaboration, CCSA is excited to provide support in trial monitoring of COG-sponsored investigational research in pediatric patients with relapsed/refractory acute myeloid leukemia (R/R-AML) with an isocitrate dehydrogenase-2 (IDH2) mutation. To learn more about this study, please refer to the clinicaltrials.gov link.
For further information regarding COG’s research program, please refer to the following link: https://www.childrensoncologygroup.org/.
